BRIEF published on 04/04/2024 at 15:05, 1 year 8 months ago First Phase 2 Clinical Trial of Lassa Fever Vaccine Begins in Nigeria Phase 2 Clinical Trial Global Health Lassa Fever Vaccine IAVI CEPI
PRESS RELEASE published on 04/04/2024 at 15:00, 1 year 8 months ago Participants in Nigeria Vaccinated in First-Ever Phase 2 Lassa Fever Vaccine Clinical Trial, Sponsored by IAVI CEPI-funded study in Nigeria evaluates safety, tolerability, and immunogenicity of IAVI's Lassa fever vaccine candidate. First Phase 2 trial for any Lassa vaccine Phase 2 Trial IAVI CEPI Lassa Fever Vaccine Candidate
PRESS RELEASE published on 12/18/2023 at 15:00, 1 year 11 months ago IAVI and Zendal Announce Funding for Efficacy Trial of Promising TB Vaccine Candidate in Africa
PRESS RELEASE published on 07/07/2023 at 15:00, 2 years 5 months ago Germany Issues Award to IAVI to Support Development of the MTBVAC Tuberculosis Vaccine Candidate
PRESS RELEASE published on 06/27/2023 at 15:00, 2 years 5 months ago IAVI Starts First-in-Human Phase I Clinical Trial of Single-Dose Sudan Virus Vaccine Candidate
PRESS RELEASE published on 05/17/2023 at 15:00, 2 years 7 months ago Zendal and IAVI Announce Expanded Agreement to Partner on Development of TB Vaccine Candidate MTBVAC
PRESS RELEASE published on 03/02/2023 at 15:00, 2 years 9 months ago IAVI and BARDA Expand Partnership to Advance IAVI's Filovirus Vaccine Candidates
Published on 12/17/2025 at 15:00, 7 hours 5 minutes ago BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 8 hours 5 minutes ago UniDoc Completes H3 Health Cube Installation in Italy
Published on 12/17/2025 at 13:35, 8 hours 30 minutes ago Silver X Mining Announces Grant of Incentive Stock Options and Restricted Share Units
Published on 12/17/2025 at 13:15, 8 hours 50 minutes ago Aclara Wins UN Global Compact Award for Its Contribution to Local Employment and Suppliers
Published on 12/17/2025 at 13:00, 9 hours 5 minutes ago Gold Terra Provides a Summary of 2025 Achievements and 2026 Plan
Published on 12/17/2025 at 21:22, 43 minutes ago EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share
Published on 12/17/2025 at 20:12, 1 hour 53 minutes ago EQS-Adhoc: Rheinmetall AG: Executive Board decides to sell activities of the civil division Power Systems – Target is sale in the first quarter of 2026; update of outlook for continuing operation
Published on 12/17/2025 at 19:39, 2 hours 26 minutes ago Avolta awarded Shanghai Pudong International Airport concession, marking a first-in-a-generation duty-free win for an international operator in mainland China
Published on 12/17/2025 at 19:10, 2 hours 55 minutes ago Holand Automotive Group Announces the sale of Ferrari Rancho Mirage to Lapis Automotive Group
Published on 12/17/2025 at 18:39, 3 hours 26 minutes ago EQS-Adhoc: centrotherm international AG: Centrotherm AcquiCo AG submits request for the squeeze-out of minority shareholders of centrotherm international AG
Published on 12/17/2025 at 20:39, 1 hour 26 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 1 hour 26 minutes ago Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 2 hours 35 minutes ago Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 4 hours 5 minutes ago Outstanding Shares and Voting Rights Statement at 30 November 2025
